American Journal of Nephrology

Papers
(The TQCC of American Journal of Nephrology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy366
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage86
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review61
Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present47
Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents46
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial46
Starvation Ketosis and the Kidney41
New Onset Biopsy-Proven Nephropathies after COVID Vaccination35
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome35
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis33
Efficacy and Safety of Molidustat for Anemia in ESA-Naive Nondialysis Patients: A Randomized, Phase 3 Trial32
Machine Learning for Prediction and Risk Stratification of Lupus Nephritis Renal Flare31
The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease30
Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study28
Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel26
The Forgotten Antiproteinuric Properties of Diuretics25
Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives22
Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)22
Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes22
Epidemiology and Outcomes of Acute Kidney Diseases: A Comparative Analysis21
High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study20
LRG1 Mitigates Renal Interstitial Fibrosis through Alleviating Capillary Rarefaction and Inhibiting Inflammatory and Pro-Fibrotic Cytokines20
Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption20
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients19
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies19
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease19
IL-6 Is Associated with Progression of Coronary Artery Calcification and Mortality in Incident Dialysis Patients19
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)18
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics18
Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis18
Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System18
Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial18
Cardiovascular Risk Prediction in Chronic Kidney Disease17
Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients17
Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease16
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review16
Diagnostic Performance of Office versus Ambulatory Blood Pressure in Kidney Transplant Recipients15
Impact of Polypharmacy on Health-Related Quality of Life in Dialysis Patients14
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial14
Impact of Sleep Duration on Mortality and Quality of Life in Chronic Kidney Disease: Results from the 2007–2015 KNHANES14
Life’s Essential 8 and Mortality in US Adults with Chronic Kidney Disease13
Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers13
Physical Exercise Improves Cognitive Function in Older Adults with Stage 3–4 Chronic Kidney Disease: A Randomized Controlled Trial13
Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients13
Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population12
Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia12
Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia12
Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes12
Association between the Estimated Glomerular Filtration Rate and Brain Atrophy in Older Adults11
Prevalence and Outcomes Associated with Hyperuricemia in Hospitalized Patients with COVID-1911
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists11
Urinary Epidermal Growth Factor: A Promising “Next Generation” Biomarker in Kidney Disease11
Mass Screening Is Associated with Low Rates of Acute Kidney Injury among COVID-19 Patients in Hong Kong10
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial10
Incidence of Serum Creatinine Monitoring and Outpatient Visit Follow-Up among Acute Kidney Injury Survivors after Discharge: A Population-Based Cohort Study10
Urine Alpha-1-Microglobulin Levels and Acute Kidney Injury, Mortality, and Cardiovascular Events following Cardiac Surgery10
Predictors of Kidney Outcomes of Anti-Glomerular Basement Membrane Disease in a Large Chinese Cohort10
Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients10
Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation9
Small Intestinal Phosphate Absorption: Novel Therapeutic Implications9
Assessment of Exercise Intolerance in Patients with Pre-Dialysis CKD with Cardiopulmonary Function Testing: Translation to Everyday Practice9
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan9
Trends in Peritoneal Dialysis Technique Survival, Death, and Transfer to Hemodialysis: A Decade of Data from the RDPLF9
Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide9
Dietary Omega-3 Fatty Acid Intake and Mortality in CKD Population: A 1999–2014 NHANES Analysis9
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient9
Clinical Outcomes of Persistent Severe Acute Kidney Injury among Patients with Kidney Disease Improving Global Outcomes Stage 2 or 3 Acute Kidney Injury9
Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis9
Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis9
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism8
Accuracy of Anti-GBM Antibodies in Diagnosing Anti-Glomerular Basement Membrane Disease: A Systematic Review and Meta-Analysis8
Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage8
Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013–20178
Epidemiology of Hypertension among Patients on Peritoneal Dialysis Using Standardized Office and Ambulatory Blood Pressure Recordings8
Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort8
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients8
Frequency and Severity of Moral Distress in Nephrology Fellows: A National Survey8
Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors8
Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based Database8
Association of Self-Reported Nighttime Sleep Duration with Chronic Kidney Disease: China Health and Retirement Longitudinal Study8
Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study8
Association between Serum Klotho and Kidney Stones in US Middle-Aged and Older Individuals with Diabetes Mellitus: Results from 2007 to 2016 National Health and Nutrition Survey8
Congenital Heart Disease in Adults with Autosomal Dominant Polycystic Kidney Disease8
Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes7
Challenges and Approach to Identifying Individuals with Salt Sensitivity of Blood Pressure7
Preimplantation Genetic Testing for Kidney Disease-Related Genes: A Laboratory’s Experience7
The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?7
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol7
Altered Intestinal Microbial Flora and Metabolism in Patients with Idiopathic Membranous Nephropathy7
Clinical Outcomes and Histological Patterns in Oxalate Nephropathy due to Enteric and Nonenteric Risk Factors7
Renal Mechanisms for Hypercalciuria Induced by Metabolic Acidosis7
Renal Functional Recovery Confounding the Assessment of Contrast Nephropathy: Propensity Score Analysis7
Estimation of Baseline Serum Creatinine with Machine Learning7
Impact of Glucose Tolerance and Its Change on Incident Proteinuria: Analysis of a Nationwide Population-Based Dataset7
Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis7
0.068042993545532